A proposed modification to the Best Pharmaceuticals for Children Act to benefit pediatric oncology
Pediatr Blood Cancer
.
2012 Jul 15;59(1):3-4.
doi: 10.1002/pbc.24115.
Epub 2012 Feb 29.
Author
Michael N Needle
1
Affiliation
1
Columbia University Medical Center, Morgan Stanley Children's Hospital of New York-Presbyterian, New York, New York 10032, USA. mnn2105@columbia.edu
PMID:
22378597
DOI:
10.1002/pbc.24115
No abstract available
MeSH terms
Adolescent
Antineoplastic Agents*
Child
Child, Preschool
European Union
Female
Humans
Infant, Newborn
Legislation, Drug*
Male
Medical Assistance / legislation & jurisprudence*
Neoplasms*
Substances
Antineoplastic Agents